GENPFGENIX PHARMACEUTICALS CORP.

About GENIX PHARMACEUTICALS CORP. (GENPF)

GENIX PHARMACEUTICALS CORP. (GENPF) is a Drug Manufacturers - Specialty & Generic company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the OTCQB tier.

Genix is an innovative Canadian life sciences company focused on the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals that have been shown to deliver consistent and verifiable results in various therapeutic areas.

Products and services

The Company is an innovative Canadian life sciences company focused on the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter (“OTC”) nutraceuticals and generic pharmaceuticals that have been shown to deliver consistent and verifiable results in various therapeutic areas.

GENPF key facts

Ticker symbol

GENPF

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

1993

Estimated market cap

$2.37M (as of May 12, 2025)

Shares outstanding

59,224,131

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

10/31

Latest filing

Annual Report (Oct 31, 2024)

GENIX PHARMACEUTICALS CORP. leadership

• Sina Salehi Pirooz — CEO
• Mahmoud Aziz — President
• Danny Wayne Kent Lee — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with G